Todd Franklin Watanabe - Net Worth and Insider Trading
Todd Franklin Watanabe Net Worth
The estimated net worth of Todd Franklin Watanabe is at least $10 Million dollars as of 2024-05-27. Todd Franklin Watanabe is the See Remarks of Arcutis Biotherapeutics Inc and owns about 1,043,064 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $10 Million. Details can be seen in Todd Franklin Watanabe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Todd Franklin Watanabe has not made any transactions after 2024-05-02 and currently still holds the listed stock(s).
Transaction Summary of Todd Franklin Watanabe
Todd Franklin Watanabe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Todd Franklin Watanabe owns 1 companies in total, including Arcutis Biotherapeutics Inc (ARQT) .
Click here to see the complete history of Todd Franklin Watanabe’s form 4 insider trades.
Insider Ownership Summary of Todd Franklin Watanabe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2024-05-02 | director & President and CEO |
Todd Franklin Watanabe Latest Holdings Summary
Todd Franklin Watanabe currently owns a total of 1 stock. Todd Franklin Watanabe owns 1,043,064 shares of Arcutis Biotherapeutics Inc (ARQT) as of May 2, 2024, with a value of $10 Million.
Latest Holdings of Todd Franklin Watanabe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2024-05-02 | 1,043,064 | 9.16 | 9,554,466 |
Holding Weightings of Todd Franklin Watanabe
Todd Franklin Watanabe Form 4 Trading Tracker
According to the SEC Form 4 filings, Todd Franklin Watanabe has made a total of 38 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 1 buys and 37 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 13,783 shares on May 2, 2024, which brought Todd Franklin Watanabe around $120,463.
Insider Trading History of Todd Franklin Watanabe
- 1
Todd Franklin Watanabe Trading Performance
GuruFocus tracks the stock performance after each of Todd Franklin Watanabe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Todd Franklin Watanabe is 13.72%. GuruFocus also compares Todd Franklin Watanabe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Todd Franklin Watanabe within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Todd Franklin Watanabe's insider trading performs compared to the benchmark.
Performance of Todd Franklin Watanabe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.9 | | | | | |
| Relative Return to S&P 500(%) | 20.43 | | | | | |
Todd Franklin Watanabe Ownership Network
Todd Franklin Watanabe Owned Company Details
What does Arcutis Biotherapeutics Inc do?
Who are the key executives at Arcutis Biotherapeutics Inc?
Todd Franklin Watanabe is the director & President and CEO of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include Chief Commercial Officer Larry Todd Edwards , SVP and Chief Business Officer Matthew Richard Moore , and See Remarks Patrick Burnett .
Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary
Over the past 18 months, Todd Franklin Watanabe made 9 insider transaction in Arcutis Biotherapeutics Inc (ARQT) with a net sale of 42,938. Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 18,544 shares made by Patrick Burnett , a net sale of 13,890 shares made by Masaru Matsuda , and a net sale of 34,000 shares made by Howard G. Welgus .
In summary, during the past 3 months, insiders sold 70,053 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 21,052 shares, with a net sale of 49,001 shares. During the past 18 months, 139,468 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 36,953 shares.
Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcutis Biotherapeutics Inc Insider Transactions
Todd Franklin Watanabe Mailing Address
Above is the net worth, insider trading, and ownership report for Todd Franklin Watanabe. You might contact Todd Franklin Watanabe via mailing address: C/o Arcutis Biotherapeutics, Inc., 2945 Townsgate Road, Suite 110, Westlake Village Ca 91361.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
